BioNet Achievements

TIMELINE OF ACHIEVEMENTS OUR R&D PIPELINE
  1. Home
  2. /
  3. Achievements
BioNet Quality, trust & innovation

+

Quality, trust & innovation

BioNet has been supporting institutes and manufacturers, in particular from Asian and African countries, to build up capacity in vaccine R&D and production, through public and private partnerships of all kinds, ranging from technology transfer to joint-development. Quality, service, trust, innovation and technical excellence are embedded in every venture we undertake.
Over the years, BioNet has created unprecedented Product Development Partnerships fostering vaccine self-reliance and leading to:
  • The production and supply of billions of doses of vaccines
  • The revival of the vaccine industry in South Africa
  • The self-sufficiency of vaccine manufacturing in Asia
  • The technology transfer of Hib for producing pentavalent vaccine
  • The substantial increase of polio vaccine capacities to support the world’s Global Polio Eradication Initiative

Timeline of Achievements

[cool-timeline category=”timeline-stories” type=”horizontal” designs=”design-2″ items=”3″ autoplay=”false” start-on=”0″ skin=”default” based=”default” order=”DESC” date-format=”Y” show-posts=”20″ story-content=”full” icons=”YES” compact-ele-pos=”main-title” filter-categories=””]
Most recently BioNet has obtained licensure for its two innovative recombinant acellular pertussis vaccines in Thailand, including aP the only monovalent recombinant pertussis vaccine approved for adolescents and adults.
Our Company
Corporate Social Responsibility